Gilead Sciences, Inc.
Solid forms of an ASK1 inhibitor
Last updated:
Abstract:
Crystalline forms of 5-(4-cyclopropyl-1H-imidazol-1-yl)-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-y- l)pyridin-2-yl)-2-fluoro-4-methylbenzamide (Compound I) were prepared and characterized in the solid state: ##STR00001## Also provided are processes of manufacture and methods of using the crystalline forms.
Status:
Grant
Type:
Utility
Filling date:
2 Aug 2019
Issue date:
16 Mar 2021